A sporadic Alzheimer’s blood-brain barrier model for developing ultrasound-mediated delivery of Aducanumab and anti-Tau antibodies
Joanna M. Wasielewska(German Center for Neurodegenerative Diseases), Lotta E. Oikari(Queensland University of Technology), Jae Hee Song(The University of Queensland), Jürgen Götz(The University of Queensland), Anthony R. White(QIMR Berghofer Medical Research Institute), Alice Pébay(The Royal Melbourne Hospital), Gerhard Leinenga(The University of Queensland), Damián Hernández(The University of Melbourne), Rebecca L. Johnston(QIMR Berghofer Medical Research Institute), Wendy Lee(The University of Queensland), Liyu Chen(Shandong University), Rebecca M. Nisbet(The University of Melbourne), Juliana C.S. Chaves(Queensland University of Technology), Laura A. Milton(Queensland University of Technology)
Cited by 3
Related Papers
Genome-wide analysis of long noncoding RNA stability
|Genome Research|2012|592
Metalloenzyme-like Activity of Alzheimer's Disease β-Amyloid
|Journal of Biological Chemistry|2002|575
Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer
|Nature Genetics|2013|544
Tau Filament Formation in Transgenic Mice Expressing P301L Tau
|Journal of Biological Chemistry|2001|515
Degradation of the Alzheimer Disease Amyloid β-Peptide by Metal-dependent Up-regulation of Metalloprotease Activity
|Journal of Biological Chemistry|2006|283